Cited by 489HIV/AIDS Research and InterventionsHIV, Drug Use, Sexual RiskHIV/AIDS drug development and treatment

No New HIV Infections With Increasing Use of HIV Preexposure Prophylaxis in a Clinical Practice Setting: Figure 1.

Open access
Volk, Jonathan E., Marcus, Julia L., Phengrasamy, Tony, Blechinger, Derek, Nguyen, Dong Phuong, Follansbee, Stephen, Hare, C. Bradley·2015·Clinical Infectious Diseases

Abstract

Referrals for and initiation of preexposure prophylaxis (PrEP) for human immunodeficiency virus (HIV) infection increased dramatically in a large clinical practice setting since 2012. Despite high rates of sexually transmitted infections among PrEP users and reported decreases in condom use in a subset, there were no new HIV infections in this population.

Integrity signals

Registry

Crossref · 10.1093/cid/civ778

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Clinical practice guidelines recommend STI screening for persons taking PrEP because increased rates of STI acquisition have been described.

    “Clinical practice guidelines recommend STI screening for persons taking PrEP (80) because increased rates of STI acquisition have been described (85–87).”

    From Sexually Transmitted Infections Treatment Guidelines, 2021 (2021) · cites this paper as [87]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Volk, J. E., Marcus, J. L., Phengrasamy, T., Blechinger, D., Nguyen, D. P., Follansbee, S., & Hare, C. B.
Affiliations
  • Kaiser Permanente San Francisco Medical Center (US)
  • Kaiser Permanente (US)
Corresponding author
Volk, Jonathan E.
Venue
Clinical Infectious Diseases
Published
2015-09-01
Volume
61
Issue
10
Pages
1601-1603
ISSN
  • 1058-4838 (ISSN-L)
  • 1537-6591
OpenAlex
W1898465070
Cited by
489
References
10
Citations by year
2026: 11 · 2025: 21 · 2024: 22 · 2023: 24 · 2022: 28 · 2021: 33 · 2020: 40 · 2019: 63 · 2018: 81 · 2017: 81 · 2016: 73 · 2015: 12
FWCI
63.97
Type
journal article
Language
en
Open access
Locations
  • Clinical Infectious Diseases (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Kaiser Permanente
  • National Institute of Mental Health (T32MH019105, P30MH062246)
Topics
  • Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
  • Health Sciences › Medicine › Epidemiology › HIV, Drug Use, Sexual Risk
  • Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
Keywords
HIV pre-exposure prophylaxis, HIV prevention, HIV incidence, PrEP users, sexually transmitted infections, condom use
MeSH terms
Adult, Aged, Female, Humans, Male, Middle Aged, HIV Infections, Homosexuality, Male, Chemoprevention, Young Adult, Pre-Exposure Prophylaxis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review